| Dr Lewis Bass, MD | |
|
1 Dakota Dr Ste 210-212, New Hyde Park, NY 11042-1135 | |
| (516) 622-6196 | |
| Not Available |
| Full Name | Dr Lewis Bass |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1 Dakota Dr Ste 210-212, New Hyde Park, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457321523 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 124814 (New York) | Primary |
| Entity Name | Prohealth Care Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275596280 PECOS PAC ID: 4486544186 Enrollment ID: O20040317000468 |
News Archive
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Stereotaxis, Inc. announced today that it had priced the public offering of 6,500,000 shares of its common at a price to the public of $4.00 per share. Stereotaxis has granted the underwriters of the offering an option to purchase up to an additional 975,000 shares of common stock to cover over-allotments, if any. All of the shares in the offering are being offered by Stereotaxis. Stereotaxis expects the offering to close on October 15, 2009.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has requested through counsel that Trimeris consent to an extension of the expiration date of the tender offer for all of Trimeris' outstanding shares of common stock commenced by Arigene and the Purchaser on October 19, 2009. Arigene has requested an extension of the expiration date of the tender offer to January 15, 2010.
With this week's vote to repeal President Obama's health care reform, House Republicans struck a blow for freedom. They struck a blow for the freedom of hospitals to avoid financial penalties, no matter how many Medicare patients develop infections under their care. They struck a blow for the freedom of hospitals to avoid consequences, no matter how many Medicare patients are readmitted soon after treatment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lewis Bass, MD 31 Peacock Dr, Roslyn, NY 11576-2522 Ph: (516) 625-1944 | Dr Lewis Bass, MD 1 Dakota Dr Ste 210-212, New Hyde Park, NY 11042-1135 Ph: (516) 622-6196 |
News Archive
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Stereotaxis, Inc. announced today that it had priced the public offering of 6,500,000 shares of its common at a price to the public of $4.00 per share. Stereotaxis has granted the underwriters of the offering an option to purchase up to an additional 975,000 shares of common stock to cover over-allotments, if any. All of the shares in the offering are being offered by Stereotaxis. Stereotaxis expects the offering to close on October 15, 2009.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has requested through counsel that Trimeris consent to an extension of the expiration date of the tender offer for all of Trimeris' outstanding shares of common stock commenced by Arigene and the Purchaser on October 19, 2009. Arigene has requested an extension of the expiration date of the tender offer to January 15, 2010.
With this week's vote to repeal President Obama's health care reform, House Republicans struck a blow for freedom. They struck a blow for the freedom of hospitals to avoid financial penalties, no matter how many Medicare patients develop infections under their care. They struck a blow for the freedom of hospitals to avoid consequences, no matter how many Medicare patients are readmitted soon after treatment.
› Verified 3 days ago
Yelena Pyatov, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 27005 76th Ave, Department Of Pediatrics, New Hyde Park, NY 11040 Phone: 718-470-7700 | |
Claudine A Smith, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3000 Marcus Ave Ste 2w15, New Hyde Park, NY 11042 Phone: 855-201-4988 | |
Amber Haq, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Dakota Dr, New Hyde Park, NY 11042 Phone: 516-622-6000 | |
Boahen Owusu Kwakye, AGNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3000 Marcus Ave Ste 2w15, New Hyde Park, NY 11042 Phone: 855-201-4988 | |
Martha Arden, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2001 Marcus Ave, Suite N204, New Hyde Park, NY 11042 Phone: 347-882-1321 | |
Mrs. Adelina Fazilov, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 450 Lakeville Rd, New Hyde Park, NY 11042 Phone: 516-487-9454 Fax: 516-487-2745 | |
Dr. Anam Sarfaraz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1991 Marcus Ave, 2nd Floor, New Hyde Park, NY 11042 Phone: 516-354-1600 Fax: 516-941-4677 |